Group CEO and Managing Director

CEO Americas

Telix Pharmaceuticals Says US CMS Approves Reimbursement for Imaging Agent

Telix Pharmaceuticals says CMS grants transitional pass-through status for Gozellix

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX

IMRA Surgical Announces Collaboration with Telix Pharmaceuticals to Advance Radio-Guided Surgery Education and Training

Specialty Networks Director

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on improving the quality of life for people living with cancer and rare diseases. The Specialty Networks Director will lead business development efforts for specialty networks, driving strategy and optimizing resources to enhance healthcare through innovative Oncology solutions.

Sign up with Google

Sign in with Google